Cargando…

CORRIGENDUM: Antiplatelet Effect of Single Antiplatelet Therapy With Prasugrel and Oral Anticoagulation After Stent Implantation in a Rabbit Arteriovenous Shunt Model

Detalles Bibliográficos
Autores principales:	Torii, Sho, Yamamoto, Tadashi, Nakamura, Norihito, Ijichi, Takeshi, Yoshikawa, Ayako, Ito, Yusuke, Sugidachi, Atsuhiro, Ikari, Yuji, Nakazawa, Gaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710636/ https://www.ncbi.nlm.nih.gov/pubmed/35083392 http://dx.doi.org/10.1253/circrep.CR-66-0009

Ejemplares similares

Antiplatelet Effect of Single Antiplatelet Therapy With Prasugrel and Oral Anticoagulation After Stent Implantation in a Rabbit Arteriovenous Shunt Model
por: Torii, Sho, et al.
Publicado: (2021)

Vasodilator-stimulated phosphoprotein (VASP) is not a major mediator of platelet aggregation, thrombogenesis, haemostasis, and antiplatelet effect of prasugrel in rats
por: Ito, Yusuke, et al.
Publicado: (2018)

Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview
por: Hillegass, William B, et al.
Publicado: (2011)

Differential impact of diabetes mellitus on antiplatelet effects of prasugrel and clopidogrel
por: Niijima, Satoshi, et al.
Publicado: (2018)

Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in Canada
por: Lordkipanidzé, Marie, et al.
Publicado: (2020)

Comparison of Vascular Responses Following New‐Generation Biodegradable and Durable Polymer‐Based Drug‐Eluting Stent Implantation in an Atherosclerotic Rabbit Iliac Artery Model
por: Nakazawa, Gaku, et al.
Publicado: (2016)

Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes
por: Alexopoulos, Dimitrios, et al.
Publicado: (2013)

Comparisons of early vascular reactions in biodegradable and durable polymer-based drug-eluting stents in the porcine coronary artery
por: Ijichi, Takeshi, et al.
Publicado: (2019)

Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
por: Kiebist, Jan, et al.
Publicado: (2021)

Late neointimal volume reduction is observed following biodegradable polymer-based drug eluting stent in porcine model
por: Ijichi, Takeshi, et al.
Publicado: (2021)

In vivo assessment of anticoagulant and antiplatelet effects of Syzygium cumini leaves extract in rabbits
por: Rehman, Ahad Abdul, et al.
Publicado: (2019)

Anticoagulant Activities of Indobufen, an Antiplatelet Drug
por: Liu, Jia, et al.
Publicado: (2018)

Surgeon's guide to anticoagulant and antiplatelet medications part two: antiplatelet agents and perioperative management of long-term anticoagulation
por: Yeung, Louise Y Y, et al.
Publicado: (2016)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs
por: Hofmeier, Kathrin Scherer
Publicado: (2015)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Anticoagulants/antiplatelets: Bleeding: 14 case reports
Publicado: (2020)

Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI
por: Ki, You-Jeong, et al.
Publicado: (2021)

Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
por: Brunetti, Natale Daniele, et al.
Publicado: (2019)

Percutaneous Nephrolithotomy in Patients on Chronic Anticoagulant/Antiplatelet Therapy
por: Nerli, R B, et al.
Publicado: (2012)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)

Balancing Antiplatelet and Anticoagulant Therapies in Patients with Cardiovascular Disease
por: Carreras, Edward T., et al.
Publicado: (2013)

New aspects on efficient anticoagulation and antiplatelet strategies in sheep
por: Weigand, Annika, et al.
Publicado: (2013)

Dental management of patients receiving anticoagulant and/or antiplatelet treatment
por: Mingarro-de-León, Ana, et al.
Publicado: (2014)

Antiplatelet/Anticoagulant Agents and Chronic Subdural Hematoma in the Elderly
por: De Bonis, Pasquale, et al.
Publicado: (2013)

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
por: Beitelshees, Amber L, et al.
Publicado: (2015)

Gastrointestinal endoscopy in patients on anticoagulant therapy and antiplatelet agents
por: Zullo, Angelo, et al.
Publicado: (2017)

Antiplatelet and anticoagulation strategies for left ventricular assist devices
por: Loyaga-Rendon, Renzo Y., et al.
Publicado: (2021)

AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
por: Winzely, Maximilian, et al.
Publicado: (2021)

Practical Guide for Anticoagulant and Antiplatelet Reversal in Clinical Practice
por: Aldhaeefi, Mohammed, et al.
Publicado: (2023)

Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review
por: Confalonieri, Filippo, et al.
Publicado: (2023)

Clinical outcomes for patients on antiplatelet and anticoagulants in thoracoabdominal trauma
por: Sharp, Victoria, et al.
Publicado: (2023)

Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using aspirin and prasugrel
por: Higashiguchi, Saeko, et al.
Publicado: (2021)

Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
por: Magnani, Giulia, et al.
Publicado: (2023)

Antiplatelet effects of aspirin vary with level of P2Y(12) receptor blockade supplied by either ticagrelor or prasugrel
por: KIRKBY, N S, et al.
Publicado: (2011)

Influence of cytochrome P450 polymorphisms on the antiplatelet effects of prasugrel in patients with non-cardioembolic stroke previously treated with clopidogrel
por: Kitazono, Takanari, et al.
Publicado: (2018)

Prasugrel, a Platelet P2Y(12) Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia
por: Ohno, Kousaku, et al.
Publicado: (2016)

Device implantation for patients on antiplatelets and anticoagulants: Use of suction drain
por: Mukherjee, Sanjeev S., et al.
Publicado: (2018)

New anticoagulants and antiplatelet agents in perioperative period: Recommendations and controversies!
por: Nair, Abhijit S, et al.
Publicado: (2017)

Dual Anticoagulant/Antiplatelet Activity of Polyphenolic Grape Seeds Extract
por: Bijak, Michal, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e4hrsc6eh777t422p10d754sne